Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
03/2000
03/22/2000EP0987247A1 Itaconate derivatives used for a component of a polymer
03/22/2000EP0986585A1 Use of ylides of phosphorus as slightly nuceophilic strong bases
03/22/2000EP0986543A1 Substituted arylalkyl uracils
03/22/2000EP0986539A1 Dna-binding pyrrole and imidazole polyamide derivatives
03/22/2000EP0986538A1 Method for producing chiral 3,4-dehydroprolines
03/22/2000EP0986384A1 Inhibitors of protein isoprenyl transferases
03/22/2000EP0986382A1 Raf kinase inhibitors
03/22/2000EP0889918B1 In situ block copolymer formation during polymerization of a vinyl aromatic monomer
03/22/2000EP0804537B1 Cleaning process and composition
03/22/2000CN1050603C Prepn. of intermediate product used in process for diastereoselective synthesis of nucleosides
03/21/2000US6040422 Reacting a fluoroformamidinium salt with an n-amino protected, optionally side chain protected amino acid; then reacting product with a carboxy protected amino acid; for compounds with long term storage stability
03/21/2000US6040339 Treatment and prophylaxis of hypercholesteremia or arteriosclerosis in a mammal
03/21/2000US6040317 Sulfonamide fibrinogen receptor antagonists
03/21/2000US6040126 Open chain a-carbonyl acetanilide yellow dye-forming coupler compound
03/21/2000US6039939 N-acyl-hydroxyamino acid esters and their use
03/21/2000US6039769 Process for the preparation of highly chromatic perylene pigments
03/16/2000WO2000014065A1 Kappa agonist compounds and pharmaceutical formulations thereof
03/16/2000WO2000014064A2 Gaba uptake inhibitors having a pyrrolidine structure
03/16/2000WO2000014054A1 Unsaturated hydroximic acid derivatives as parp inhibitors
03/16/2000WO2000014048A1 Oligonucleotide protecting groups
03/16/2000WO2000013707A1 Preventives/remedies for multiple organ failure
03/16/2000WO2000005206A8 Arylpiperazine derivatives useful as uro-selective alpha-1-adrenoceptor blockers
03/16/2000WO1999064047A9 Novel antiviral compounds
03/16/2000WO1999063929A9 Multibinding inhibitors of microsomal triglyceride transferase protein
03/16/2000CA2343531A1 Gaba uptake inhibitors having a pyrrolidine structure
03/16/2000CA2342994A1 Kappa agonist compounds and pharmaceutical formulations thereof
03/16/2000CA2342898A1 Unsaturated hydroximic acid derivatives as parp inhibitors
03/16/2000CA2342796A1 Preventives/remedies for multiple organ failure
03/15/2000EP0985665A1 Process for the preparation of 3-amino-2-oxo-pyrrolidines, intermediates and use thereof
03/15/2000EP0985664A2 Method of producing pyrrolidine derivatives
03/15/2000EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
03/15/2000EP0984931A1 Aromatic maleimides and their use as photoinitiators
03/15/2000EP0984926A2 Building blocks derived from 1,2-aminoalcohols
03/15/2000EP0984778A1 Neuropeptide-y ligands
03/15/2000EP0984777A1 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
03/14/2000CA2117643C Indole derivatives
03/09/2000WO2000012515A1 Vinyl substituted cyclic products of the ene-yne reaction
03/09/2000WO2000012507A2 Pyrrolobenzodiazepines
03/09/2000WO2000012477A1 Hydroxamic acid derivatives as proteinase inhibitors
03/09/2000WO2000012087A1 Method for treating hot flashes in humans
03/09/2000WO2000012076A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000DE19840611A1 GABA-uptake-Inhibitoren mit Pyrrolidinstruktur GABA-uptake inhibitors with Pyrrolidinstruktur
03/09/2000CA2341716A1 Vinyl substituted cyclic products of the ene-yne reaction
03/09/2000CA2339189A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/08/2000EP0984003A1 Polyisobutanyl succinimides and fuel compositions containing the same
03/08/2000EP0983992A2 Compounds having selectivity for retinoid x receptors
03/08/2000EP0983991A2 Compounds having selectivity for retinoid x receptors
03/08/2000EP0983267A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
03/08/2000EP0983258A1 N-hydroxy 4-sulfonyl butanamide compounds
03/08/2000EP0983257A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
03/08/2000EP0983065A1 Gastric-retained pharmaceutical composition
03/08/2000EP0983064A1 PYRROLES AS sPLA2 INHIBITORS
03/08/2000EP0863871B1 Anticoagulant peptide aldehyde derivatives
03/08/2000CN1246899A Sizing of paper
03/08/2000CN1246861A Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds
03/08/2000CN1246847A Nitrogen containing heteroaromatics as factor Xa inhibitors
03/08/2000CN1246845A Fungicidal carboxamides
03/08/2000CN1246792A N-linked sulfonamides of heterocyclic thioesters
03/08/2000CN1246331A Hair dye composite for keratin fibre containing cation direction dye and polymer thickening agent
03/08/2000CN1246330A Keratin fibre hair dye composite containing cation direction dye and polymer thickening agent
03/08/2000CA2281393A1 Method of producing pyrrolidine derivatives
03/07/2000USRE36607 Pyrrolidine compounds and process of preparing
03/07/2000US6034275 Tertiary amines
03/07/2000US6034273 N-(arylmethylene)-1-chloro-1-(perfluoroalkyl) methylamine compounds
03/07/2000US6034253 Process for the preparation of 5-(alkoxymethyl)-2,3-pyridinedicarboximide compounds
03/07/2000US6034247 Reactig a unsatursated carboxylated amine with a base; cyclization
03/07/2000US6034195 Thermosetting resin compositions containing maleimide and/or vinyl compounds
03/07/2000US6034194 Blend containing unsaturated compound and peroxide free radical catalyst
03/07/2000US6034150 Polymerization processes using aliphatic maleimides
03/07/2000US6034131 Diphenylethers, process and intermediate products for their preparation, and their use
03/07/2000US6034104 Anticoagulant agents
03/07/2000US6034093 Anticoagulants
03/02/2000WO2000010974A2 Process for the preparation of a maleimide compound, maleimide compound, radiation-curable compositions comprising said compound and coated products
03/02/2000WO2000010565A1 Growth hormone secretagogues
03/02/2000WO1999064054A9 Multibinding inhibitors of topoisomerase
03/02/2000WO1999064043A9 Muscarinic receptor antagonists
03/02/2000WO1999063937A3 Multivalent macrolide antibiotics
03/02/2000DE19839565A1 N-vinyl-lactam(s) production
03/01/2000EP0982323A1 Aminocarbamates of polyalkyl or polyalkenyl N-hydroxyalkyl succinimides and fuel compositions containing the same
03/01/2000EP0982322A1 Ethers of polyalkyl or polyalkenyl N-hydroxyalkyl succinimides and fuel compositions containing the same
03/01/2000EP0982321A1 Esters of polyalkyl or polyalkenyl n-hydroxyalkyl succinimides and fuel compositions containing the same
03/01/2000EP0982300A2 Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
03/01/2000EP0982297A2 Process for the preparation of hydroxy-pyrrolidinyl hydroxamic acid derivatives being opioid kappa receptor agonists
03/01/2000EP0982293A1 Process for the preparation of imines and enamines, and possibly their further hydrogenation into amines
03/01/2000EP0981526A1 Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
03/01/2000EP0513387B1 Thiazole derivatives as active oxygen inhibitors
03/01/2000CN1246109A 5-aroylnaphthalene derivatives
03/01/2000CN1245799A Preparation method of pyrrolidyl hydroxamic acid compound
02/2000
02/29/2000US6031130 Catalyzing the dehydration of a secondary amine compound by adding a rhenium catalyst and aqueous hydrogen peroxide to a mixture also containing a dehydrating agent; use as photographic developers, additives for polymers
02/29/2000US6031114 Process for pyrrolidinyl hydroxamic acid compounds
02/29/2000US6031113 Method of producing 4-hydroxy-2-pyrrolidinone and method of purifying the same
02/29/2000US6031110 Ortho-substituted 2-methoxyiminophenyl-N-methylacetamides
02/29/2000US6030985 Stroke, schizophrenia, antianxiolytic and antihypoxia agents, analgesics; neurodegenerative disorders, e.g., nerve degeneration and/or necrosis; hyperglycemic, antiepileptic and antiinflammatory agents; drug abuse;
02/29/2000US6030972 2- or 5-aminomethyl,2- or 5-cyanopyrimidines as intermediates of anticoagulants in extracorporeal circulation (heart-lung machine, hemodialysis)
02/29/2000CA2017535C Antispasmodic agents
02/28/2000CA2280226A1 Aminocarbamates of polyalkyl or polyalkenyl n-hydroxyalkyl succinimdes and fuel compositions containing the same
02/28/2000CA2280225A1 Esters of polyalkyl or polyalkenyl n-hydroxyalkyl succinimdes and fuel compositions containing the same
02/28/2000CA2280224A1 Ethers of polyalkyl or polyalkenyl n-hydroxyalkyl succinimdes and fuel compositions containing the same
02/28/2000CA2272041A1 Polyisobutanyl succinimides and fuel compositions containing the same
02/24/2000WO2000009482A1 Trifluoro methylpyrrol carboxamides